Sutro Biopharma (STRO) Share-based Compensation Growth (1y) (2017 - 2026)
Powered by 
Analysis
Sutro Biopharma (STRO) Share-based Compensation Growth (1y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 71.86% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -3.46% |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -7.69% |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | -8.89% |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | -22.43% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | -4.01% |
| 10 | Sutro Biopharma | 334.66 Mn | 170.32 Mn | - | -79.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -79.10% |
| Dec 31, 2025 | -72.02% |
| Sep 30, 2025 | -12.39% |
| Jun 30, 2025 | -68.47% |
| Mar 31, 2025 | -2.81% |
| Dec 31, 2024 | -4.95% |
| Sep 30, 2024 | 12.42% |
| Jun 30, 2024 | 265.20% |
| Mar 31, 2024 | 4.96% |
| Dec 31, 2023 | 6.34% |
| Sep 30, 2023 | 5.98% |
| Jun 30, 2023 | 11.25% |
| Mar 31, 2023 | 15.09% |
| Dec 31, 2022 | -15.03% |
| Sep 30, 2022 | 15.07% |
| Jun 30, 2022 | 27.09% |
| Mar 31, 2022 | 83.29% |
| Dec 31, 2021 | 123.10% |
| Sep 30, 2021 | 108.71% |
| Jun 30, 2021 | 96.18% |